癌症幸存者自然妊娠率与结局的系统综述
该系统综述检索MEDLINE、Embase、Cochrane Library和Scopus至2025年4月24日,纳入43篇文章,分析癌症幸存者自然妊娠的活产率及母胎结局。乳腺癌幸存者及接受造血干细胞移植或腹盆腔放疗者活产率显著较低,乳腺癌和妇科癌症幸存者流产率较高,放疗暴露者小于胎龄儿或低出生体重儿风险较高,乳腺癌幸存者医源性或自发性早产风险较高。
要点
- 乳腺癌幸存者及接受造血干细胞移植或腹盆腔放疗者自然妊娠活产率显著较低。
- 乳腺癌和妇科癌症幸存者自然妊娠流产率较高,但妊娠期高血压疾病、妊娠期糖尿病、胎盘异常和癌症复发率无差异。
- 放疗暴露幸存者小于胎龄儿或低出生体重儿风险较高,乳腺癌幸存者医源性或自发性早产风险较高。
核心结论
- 尽管癌症患者自然妊娠是可能的,但某些癌症和治疗与活产率降低及产科和新生儿并发症增加相关。
- 在癌症诊断和治疗过程中进行个体化生育力保留咨询是综合癌症照护的重要方面,有助于患者对未来生育做出知情决策。
研究设计与样本
- 系统综述,检索MEDLINE(PubMed)、Embase(Elsevier)、Cochrane Library(Wiley)和Scopus(Elsevier),从建库至2025年4月24日。
- 去重后对1,185条唯一引文由两名研究者进行盲法独立审查,对300篇报告和64条二级引文进行全文筛选,最终提取43篇文章的数据。
主要发现
- 乳腺癌幸存者及接受造血干细胞移植或腹盆腔放疗者的活产率显著较低。
- 乳腺癌和妇科癌症幸存者的流产率较高,但妊娠期高血压疾病、妊娠期糖尿病、胎盘异常或癌症复发率无差异。
- 放疗暴露幸存者小于胎龄儿或低出生体重儿风险较高,乳腺癌幸存者医源性或自发性早产风险较高。
- 其他类型癌症或治疗与活产率或任何次要结局无显著差异。
临床怎么用
- 作者认为,在癌症诊断和治疗过程中进行个体化生育力保留咨询是综合癌症照护的重要方面,有助于患者对未来生育做出知情决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: This systematic review investigates outcomes for unassisted pregnancies in cancer survivors. Although prior studies have examined pregnancy outcomes for cancer survivors, clarifying the outcomes specifically for unassisted pregnancies can help guide patient and provider expectations and improve fertility preservation counseling. OBJECTIVE: The primary objective of this systematic review was to identify the impacts of cancer and its treatment on fertility, measured as the live birth rate among cancer survivors with an unassisted pregnancy. Secondary objectives included identifying parental and fetal outcomes of unassisted pregnancies in cancer survivors. EVIDENCE REVIEW: We searched MEDLINE (PubMed), Embase (Elsevier), Cochrane Library (Wiley), and Scopus (Elsevier) from inception through April 24, 2025. After de-duplication, 1,185 unique citations were subject to blinded independent review by two investigators. Full-text screening was performed on 300 reports and 64 secondary citations. Data extraction was completed for 43 articles for the primary outcome of live birth rates and secondary outcomes. FINDINGS: This review consolidates the available data on the outcomes of unassisted pregnancies in cancer survivors compared with individuals without cancer. Live birth rates were significantly lower in survivors of breast cancer and individuals who underwent hematopoietic stem cell transplant or abdominopelvic radiation therapy during their cancer treatment. Survivors of breast and gynecologic cancers had higher rates of pregnancy loss, although there were no differences in rates of hypertensive disorders of pregnancy, gestational diabetes, placental abnormalities, or cancer recurrence. Survivors exposed to radiation therapy were more likely to have infants who were small for gestational age or had low birth weight, and survivors of breast cancer were more likely to experience iatrogenic or spontaneous preterm birth. The effects of other types of cancers or treatments were not associated with significant differences in live birth rates or any secondary outcomes in included studies. CONCLUSION AND RELEVANCE: Although unassisted pregnancy is possible for patients diagnosed with cancer, certain cancers and treatments are associated with decreased live birth rates and increased obstetric and neonatal complications. Individualized fertility preservation counseling throughout the cancer diagnosis and treatment process is an important aspect of comprehensive cancer care that helps patients make informed decisions about their future fertility.
引用
- Potapragada NR, Beestrum M, Goldman KN, et al. Unassisted pregnancy rates and outcomes in cancer survivors: a systematic review. Fertil Steril. 2025. PMID: 40848826. doi:10.1016/j.fertnstert.2025.08.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。